ReviewViruses2022

On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy.

Daniele Focosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.